Stocks making the biggest moves midday: Apple, Meta Platforms, Bumble, Fermi, Goldman Sachs & more

Apple shares rose 1% after unveiling HomeView, a smart home hub powered by Apple Intelligence and Siri with facial recognition for multiple people.

Likely modest upward drift as investors react to the product launch and AI positioning.

The article ties the same-day move to a specific Apple product unveiling, but provides no financial guidance or adoption metrics.

Meta shares climbed more than 2% for a second day after rolling out its Muse Wonder AI model, which was well received by Wall Street.

Likely continued support as traders extrapolate early reception of the new AI model.

The catalyst is explicit and same-day, but the piece does not quantify user impact or revenue implications.

Bumble shares surged 56% after announcing an all-cash acquisition by Ithaca Holdings valuing the company at $1.3 billion.

Likely further volatility upward as deal terms are digested and merger-risk hedging begins.

The article reports a clear, material acquisition with a large same-day move and a stated $1.3B valuation.

Advanced Micro Devices is named as the counterparty to Fermi’s credit support agreement backing Project Matador’s first phase in Texas.

Likely modest upside or stabilization as the market links AMD to funded AI buildout.

AMD is mentioned as a partner, but the article does not state AMD’s direct financial terms or immediate revenue impact.

Goldman Sachs shares rose nearly 1% after reporting Q3 revenue of $18.68 billion, exceeding an LSEG estimate of $16.71 billion.

Likely mild upward follow-through as the market digests the revenue outperformance.

The piece includes a concrete earnings datapoint and same-day price reaction, but lacks guidance or EPS detail.

JPMorgan Chase shares were marginally higher after raising its net interest income outlook for the year, despite earnings and revenue missing expectations.

Likely range-bound to slightly positive as investors weigh the outlook lift against the miss.

The article cites both an outlook change and a miss, implying a tempered reaction rather than a clean directional catalyst.

UnitedHealth shares were up less than 1% after posting third-quarter results that beat analyst expectations on adjusted EPS and revenue.

Likely modest support rather than a breakout move.

The article provides beat figures but indicates the stock reaction was small, suggesting expectations were already close.

Johnson & Johnson shares slid more than 6% after better-than-expected results were offset by soft medical device sales.

Likely continued downside pressure until investors get clarity on MedTech demand trajectory.

The article directly links the large drop to a specific segment shortfall.